Medtronic, Inc. (NYSE:MDT) - FDA Approves Expanded MRI labeling For Medtronic's Sacral Neuromodulation Systems
The FDA has approved expanded MRI labeling of Medtronic plc's (NYSE: MDT) InterStim II and InterStim Micro sacral ...
Source: benzinga.com